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ABSTRACT 
Calcium/calmodulin dependent protein kinase II (CaMKII) acts as a molecular switch 
regulating cardiovascular Ca2+ handling and contractility in health and disease. Activation of 
CaMKII is also known to regulate cardiovascular inflammation and is reported to be 
required for pro-inflammatory NF-B signalling. In this study the aim was to characterise 
how CaMKII interacts with and modulates NF-B signalling and whether this interaction 
exists in non-contractile cells of the heart. Recombinant or purified CaMKII and the 
individual inhibitory -B kinase (IKK) proteins of the NF-B signalling pathway were used in 
autoradiography and Surface Plasmon Resonance (SPR) to explore potential interactions 
between both components. Primary adult rat cardiac fibroblasts were then used to study the 
effects of selective CaMKII inhibition on pharmacologically-induced NF-B activation as 
well as interaction between CaMKII and specific IKK isoforms in a cardiac cellular setting. 
Autoradiography analysis suggested that CaMKII phosphorylated IKKbut not IKK. SPR 
analysis further supported a direct interaction between CaMKII and IKKbut not between 
CaMKII and IKK or IKK CaMKII regulation of Idegradation was explored in adult 
cardiac fibroblasts exposed to pharmacological stimulation. Cells were stimulated with 
agonist in the presence or absence of a CaMKII inhibitor, autocamtide inhibitory peptide 
(AIP). Selective inhibition of CaMKII resulted in reduced NF-B activation, as measured by 
agonist-stimulated IB degradation. Importantly, and in agreement with the recombinant 
protein work, an interaction between CaMKII and IKK  was evident following Proximity 
Ligation Assays in adult cardiac fibroblasts. This study provides new evidence supporting 
direct interaction between CaMKII and IKK  in pro-inflammatory signalling in cardiac 
fibroblasts and could represent a feature that may be exploited for therapeutic benefit. 

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1. Introduction 
 
CaMKII is a multi-functional serine/threonine kinase which is now well recognised as 
being constitutively expressed in the heart (the  isoform being predominant), where it serves 
to regulate normal calcium (Ca2+) homeostasis, contractility, metabolism and gene expression. 
Crucially, CaMKII becomes hyper-activated in pathophysiological conditions and this 
sustained activation is known to contribute to heart failure, arrhythmia and cell death [1]. 
Cardiovascular disease is a very complex and dynamic process involving not only the cardiac 
muscle, but also the vasculature and different cell types within both. Non-contractile cells of 
the heart, predominantly cardiac fibroblasts (CFs), play a key role in normal cardiac function 
through their fundamental role in extracellular matrix deposition as well as their ability to 
modulate contractile cell activity via secretion of bioactive molecules. Under conditions of 
stress however, these cells become hyperproliferative and contribute to fibrotic remodelling of 
the heart and contractile dysfunction [2]. The possibility that CaMKII may have an 
overarching role in non-contractile cell types of the cardiovascular system in health and 
disease has yet to be established.  
A key component in the progression of cardiovascular disease is chronic 
inflammation. Levels of inflammatory mediators increase as cardiac function deteriorates and 
these are significantly elevated in the failing heart [5]. This chronic inflammatory phenotype 
is also evident in vascular disease, which subsequently leads to endothelial dysfunction 
underpinning pathologies such as atherosclerosis and hypertension [6,7]. The transcription 
factor Nuclear Factor kappa B (NF-B) has been identified as an important mediator of 
cardiovascular inflammatory status, where activation of the NF-B signalling pathway has 
been implicated as a causal event in cardiac hypertrophic progression [8] and vascular 
endothelial dysfunction [9]. Activation of NF-B requires phosphorylation and release of an 
associated inhibitory protein IB. The IB protein is subsequently degraded and NF-B can 
translocate to the nucleus and induce gene transcription. IB degradation can therefore be 
used as a marker of activation of NF-B signalling. The enzymes that cause phosphorylation 
and release of IB are known as IB kinases (IKKs) and these form the IKK complex, 
composed of IKKα, β and γ. Both α and β are active kinases whereas IKKγ (also known as 
NEMO-NF-B essential modulator) functions solely as a scaffold component of the complex 
[10]. Although the IKKs are well defined as key modulators of IB degradation, the potential 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
exists that other kinases may mediate this pathway either via direct phosphorylation and 
modulation of IKK activity or via direct phosphorylation of IB.  
Observations that inhibitors of calmodulin led to prevention of IB phosphorylation prompted 
speculation that CaMKII (a calmodulin-dependent kinase) may be involved in NF-B 
modulation [11]. Several studies have suggested that CaMKII may regulate NF-B and that 
this may occur at the level of the IB kinase [12,13]. A link between these pathways in the 
cardiovascular system has also been made. Studies performed in neonatal cardiac myocytes 
have shown that overexpression of CaMKIIδ increases NF-B activity while inhibition of 
CaMKII (using KN-93) attenuates activity [14]. Increased NF-B activity in response to 
activated CaMKIIδ leads to hypertrophic responses in these cells. More recent work has 
shown that CaMKII inhibition with AC3-I (an inhibitory peptide) markedly reduces 
upregulation of pro-inflammatory genes induced by myocardial infarction [15]. One of these 
genes (complement factor B (Cfb)) was induced through activation of the NF-B pathway by 
CaMKII. Suppression of NF-B activity by AC3-1-mediated inhibition of CaMKII led to 
reduced Cfb expression and sarcolemmal injury following infarction. A separate in vivo study 
in wild type and cardiac-specific CaMKII knockout mice has demonstrated that CaMKII 
mediates NF-B activation in cardiac myocytes and the development of apoptosis and 
inflammation following ischaemia-reperfusion [16]. Evidence strongly suggests that 
CaMKII modulates pro-inflammatory NF-B signalling in the contractile cells of the heart. 
Could this relationship also exist in the non-contractile cardiac fibroblasts and, if so, how is it 
mediated? 
  Here for the first time, we investigate the potential for CaMKIIδ to modulate pro-
inflammatory NF-B signalling in adult cardiac fibroblasts. Using recombinant proteins for 
Surface Plasmon Resonance (SPR) along with autoradiography analysis, we have investigated 
whether CaMKIIδ may modulate NF-B signalling by targeting specific components of the 
IKK complex. Building upon this work, we have shown that CaMKII modulates NFB 
signalling in primary adult rat cardiac fibroblasts. We have provided novel evidence for 
interaction of CaMKIIδ specifically with IKKβ in these cells and for the first time, have 
highlighted the potential for CaMKIIδ modulation of NF-B signalling at the level of IKK  in 
these non-contractile cells of the heart.  
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2. Methods 
2.1 Isolation of adult rat cardiac fibroblasts  
 
Adult rats (male Sprague Dawley, ~350-400g) were used to isolate CFs under sterile 
conditions. Procedures complied with the ARRIVE guidelines and conformed to the Guide for 
the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996) and Directive 2010/63/EU of the European Parliament. 
Hearts were dissected immediately following termination by intravenous injection with 
pentobarbital sodium (10µl/g weight of animal; Euthatal) and heparin (0.1µl/g weight of 
animal; 5000 units/ml). For CF isolation, a chunk dissociation protocol using collagenase type 
II was followed as previously described [17]. Cells were subsequently collected by 
centrifugation and re-suspended in Dulbecco’s modified Eagle medium (DMEM; GIBCO 
21969) supplemented with 20% foetal calf serum (heat-inactivated; GIBCO), 1% (v/v) L-
glutamine (GIBCO) and 4% (v/v) Pen/Strep.  Cells were grown to 60-80% confluence in T75 
flasks at 37˚C in an atmosphere of 5% CO2 with media changed every second day. Cells were 
only used for experimental work up to passage 3. 
 
2.2 Preparation of cardiac homogenates 
Hearts were isolated, finely minced on ice and whole tissue homogenates prepared as 
previously described [18]. 
 
2.3 Immunoblotting  
Cells grown on a 12-well plate 48h prior to assay were solubilised with addition of 
150 μl 1X Laemmli sample buffer containing 75mM DTT.  Cells were scraped from the 
bottom of wells and DNA disrupted by dispersion through a 28G needle.  Samples were then 
heated to 70ºC for 10 min prior to loading onto either 7% (v/v) Tris-acetate or 10% (v/v) Bis-
Tris polyacrylamide gels (Invitrogen) and analysed by SDS-PAGE using the Invitrogen 
NuPAGE® system. Following transfer of proteins to nitrocellulose, membranes were blocked 
in 5% (w/v) nonfat dry milk diluted in TBST buffer (20 mM Tris-base, 137 mM NaCl and 0.1 
% (v/v) Tween 20, pH 7.6) for 1h at room temperature, then incubated overnight at 4ºC with 
antibodies against IKKα, IKKβ (both mouse monoclonal antibody 1:500 (Calbiochem 
(#OP133 and OP134 respectively), IB(rabbit polyclonal 1:1000 (Cell Signalling 
Technology #4814)) or CaMKIIδ (rabbit polyclonal antibody 1:1000, custom-made against 
the C-terminus of CaMKII (Eurogentec)) prepared in 5% (w/v) BSA in TBST.  All primary 
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antibodies were chosen based on their ability to react specifically with rat. This was followed 
by incubation for 2 h at room temperature with either goat anti-mouse IgG-HRP (Jackson 
Immunoresearch #715-035-150) or goat anti-rabbit IgG-HRP (Sigma-Aldrich #A6154) 
diluted 1:5,000 and 1:10,000 respectively and development using the ECL detection system 
(Thermo Fisher #32106).  
For quantitative analysis of IB, GAPDH was also measured as an internal loading 
control for these samples (mouse monoclonal 1:40,000 (Abcam #ab8245) followed by anti-
mouse IgG-HRP 1:5,000). Both IB and GAPDH were probed on the same blot. After 
incubation in ECL reagent and development of films, signals from the scanned immunoblots 
were quantified by densitometry using a GS-800 densitometer and Quantity One Image 
software (version 4.5.2, BioRad) and signals expressed as ratios (IB:GAPDH). 
 
2.4 Immunofluorescence 
CFs, aortic endothelial cells and colonic vascular smooth muscle cells were grown on 
coverslips until confluent and fixed by aspirating the culture medium and applying 4% (v/v) 
paraformaldehyde for 10 min. Cells were then exposed to cold methanol for 10 min. This was 
followed by washing 3 times with PBS and permeabilisation with Triton X-100 (0.01% (v/v)) 
for 10 min. Non-specific binding was blocked using 1% (w/v) Bovine Serum Albumin (BSA) 
in Phosphate Buffered Saline (PBS) for 1h at room temperature followed by direct addition of 
primary antibody overnight at 4°C.  Primary antibodies (vimentin (abcam #Vim3B4), α-
smooth muscle actin (Sigma-Aldrich #A5228), CD31 (Sigma-Aldrich #P8590) and von 
Willebrand Factor (abcam #ab194405)) were prepared with 1% (w/v) BSA in sterile PBS at a 
1:100 dilution. Following washes in PBS anti-mouse IgG-FITC (Sigma-Aldrich#FO257) 
(1:1,000) and anti-rabbit IgG- Alexa Fluor 594 (Thermo Fisher #A11032) (1:400) 
respectively were then applied for 1h at room temperature. After washing, coverslips were 
mounted on to slides using Mowiol® (SigmaAldrich) mounting medium containing DAPI 
(Vecta laboratory) and stored at 4°C in the dark until they were viewed and photographed. 
The DAPI counter-stain in the mounting medium stained the cell nuclei blue. Slides were then 
viewed using a Zeiss Axio Imager microscope (Carl Zeiss MicroImaging GmbH, Germany)  
under a 20x and 10x lens (NA 0.50). Fluorescence was stable allowing digital images to be 
captured using AxioVision v.4.6 (Zeiss, Germany). 
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2.5 Autoradiography  
Assay components consisted of 30ng CaMKII and 100 ng IKKα (GST-tagged) or 
IKKβ (His-tagged) (all Human recombinant, Millipore). Autocamtide II (50M) (Millipore), 
the CaMKII peptide substrate, was included as a positive control for CaMKII 
phosphorylation. In some samples, Autocamtide Inhibitory Peptide (AIP) (Calbiochem) was 
included to inhibit CaMKII activity.  Components were mixed with 2 μg calmodulin 
(Calbiochem), 1.5 mM CaCl2 (final concentration) and 50 μM ATP/2 μCi [γ-
32P]ATP (final 
concentration (PerkinElmer)) and incubated at 30ºC in assay dilution buffer (ADB) for 30min. 
ADB consisted of 20 mM HEPES (pH 7.6), 25 mM MgCl2, 2 mM DTT, 20 mM β-
Glycerophosphate and 0.5 mM sodium orthovanadate. Reactions were terminated on ice by 
addition of Laemmli sample buffer containing 32 mg/ml DTT.  Samples were loaded onto a 
10% (v/v) acrylamide gel and analysed by SDS-PAGE using the BioRad system. Gels were 
subjected to electrophoresis at a constant voltage of 140 mV for 1.5 h and were then left 
overnight in 20 ml fixer solution (40% (v/v) methanol and 10% (v/v) acetic acid). After 24 h 
gels were rehydrated in dH20 for ~30 min before the drying of gels at a medium heat for ~1 h.  
Protein phosphorylation was then examined by autoradiography. 
 
2.6 Surface Plasmon Resonance  
Studies were performed using a Biacore 3000 instrument and were based on an SPR 
protocol described previously [19].  Briefly, CaMKII (Human recombinant, Millipore) was 
immobilised on to a CM5 sensor chip at ~ 7pg/mm2. Immobilisation was performed at 25oC at 
a flow rate of 5l/min using SPR running buffer (20mM Hepes, pH7.4, 150mM NaCl, 
0.005% (v/v) surfactant P20). All experiments used BSA as a negative control with equivalent 
amounts of protein immobilised under exactly the same conditions as for CaMKIIδ. Prior to 
starting any experiments, the system was primed with binding buffer (running buffer + 5mM 
MgCl2, 1.5 mM CaCl2 and 2mM DTT). Calmodulin (CaM), IKKα (GST-tagged), IKKβ (His-
tagged) and IKK (GST-tagged) (all Human recombinant, Millipore) were prepared in 
binding buffer at final concentrations of 0.0125 - 0.2 μM in running buffer and were injected 
randomly for 3 min (association phase) on to the flow cell at a rate of 30 μl/min followed by a 
15 min dissociation period. In experiments investigating the effect of Ca2+, imidazole and 
ATP on protein-protein interactions, SPR running buffer had no added CaCl2 or contained 
100mM imidazole or 1mM ATP respectively. Interactions were followed in real time on a 
sensorgram.  After each measuring cycle, the sensor chip surface was regenerated with 2 x 30 
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s pulse of regeneration buffer containing 2 mM EDTA and 1 M NaCl, followed by a 2 min 
stabilisation period before another injection.  Data analysis was carried out using the 
BIAevaluation version 3.2 (Biacore). 
 
 degradation 
Prior to stimulation, CFs (passage 1-2) at 80-100% confluency were serum starved for 
24 h. CFs were treated with lipopolysaccharide (LPS, 5g/ml) over a time course up to 120 
min in the presence or absence of AIP (5M) (Merck). Where appropriate, CFs were pre-
treated with AIP for 1h prior to stimulation. After specified times, reactions were terminated 
on ice via aspiration of media and addition of 150 μl 1x Laemmli sample buffer containing 
75mM DTT.  Cells were scraped and DNA disrupted by aspiration using a 28G needle. 
Samples were analysed by quantitative immunoblotting. 
 
2.8 Proximity Ligation Assay 
The Duolink® in situ Orange Proximity Ligation Assay (PLA) was used to detect 
CaMKII-IKKβ interactions in CFs following manufacturers’ protocol (Sigma-Aldrich) and as 
previously described [20]. Optimisation of antibodies was performed initially by 
immunofluorescence (IKKβ, 1:200, mouse monoclonal (Abcam); CaMKIIδ, 1:50, rabbit 
polyclonal (Eurogentec custom-made); ox-CaMKII, 1:50, rabbit polyclonal (GeneTex). For 
subsequent PLA experiments, IKKβ and ox-CaMKII primary antibodies were used prior to 
Duolink® probe incubation. Image analysis (images captured by a confocal microscope 
equipped with LSM510 software) was performed using Image J software 
(https://imagej.nih.gov/ij/) as previously described [20]. The best threshold was set and 
images converted to black and white. Images were analysed by applying the region of interest 
(ROI) and fluorescent dots measured with minimum and maximum pixel area size set and 
cells on the edge of the image excluded. Background (ROI using exactly the same settings in 
areas where there were no cells) was subtracted for each of the experimental conditions and 
comparisons made across controls (no primary antibody), IKK  alone, IKKplus CaMKII 
and IKK  plus ox-CaMKII. 
 
2.9 Statistical analysis 
Where appropriate, data were expressed as mean values ± SEM of n observations, where n 
represents the number of samples. Comparisons were assessed using the student’s t-test or 
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one- and two-way ANOVA with Tukey’s post-test as indicated. Differences were considered 
statistically significant when p < 0.05. Where no p value is shown, p > 0.05. 
 
3. Results 
3.1 CaMKII phosphorylation of specific IKK components of the NF-B signalling pathway 
Initial experiments set out to determine whether CaMKII interacted with and/or 
phosphorylated selected IKK components of the NF-B cascade. The use of recombinant or 
purified proteins was employed to explore the potential for interaction. To assess whether 
CaMKII interacts with and phosphorylates specific IKK components of the NF-B 
signalling pathway, CaMKII (30ng) was incubated with either IKKor IKK  (each at 
100ng) in the presence of [32P] ATP (Fig. 1A). The CaMKII peptide substrate autocamtide II 
(50M) has previously been used as a positive substrate control to demonstrate CaMKII 
activity using the same amounts/activities of CaMKII and [32P]ATP [19]. Incubation of 
CaMKII with IKKand   in the presence of ATP results in phosphorylation of all three of 
these protein components (Fig. 1A, lanes 3 and 4). It is important to note that both CaMKII 
and the IKKs are capable of autophosphorylation therefore the intensity of phospho signal 
could reflect differences in CaMKII-mediated phosphorylation (of CaMKIIitself 
(autophosphorylation) and of the IKKs) and/or could show evidence for IKK 
autophosphorylation. These reactions were therefore repeated in the presence of the CaMKII 
inhibitor peptide AIP (5M). AIP will inhibit CaMKII and therefore, can potentially inhibit 
CaMKII-mediated phosphorylation of both CaMKIIand the IKKs but will not affect 
autophosphorylation of IKKs, so any decrease in signal intensity following AIP treatment will 
only be due to CaMKII-mediated effects. As expected, inclusion of AIP markedly reduced 
any autophosphorylation of CaMKII(Fig. 1A, lane 2) Interestingly, the addition of AIP also 
significantly inhibited the phosphorylation signal associated with IKK(Fig. 1A, lane 6) but 
not that associated with IKK(Fig. 1A, lane 5) Importantly, all samples were run on the 
same gel (Fig. 1A shows relevant sections taken from the same gel) and therefore were 
exposed for the same length of time. This data highlights the possibility that CaMKII may 
phosphorylate/interact selectively with IKK . In order to discount any contamination of the 
protein preparations used, purity of these preparations is shown in an accompanying 
coomassie stained gel (Fig. 1B).  
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3.2 Surface Plasmon Resonance analysis of CaMKII interaction with IKKs 
In order to assess the potential for direct interaction between CaMKII and individual 
components of the IKK complex (IKKand ), Surface Plasmon Resonance (SPR) studies 
were performed. Previous work by our group using SPR has already established the 
immobilisation and buffer conditions required for analysis of CaMKII-protein interactions 
[19]. Using the same established conditions for immobilisation of CaMKII onto the sensor 
chip, the IKK complex components were individually tested as analytes and any binding 
between IKK and CaMKII measured as a change in refractive index as previously explained 
[19]. All experiments with the experimental protein (CaMKII) were performed in parallel 
with a control protein (albumin) which was immobilised to the same final density on a second 
flow cell of the sensor chip. Any binding of the analyte of interest to the control protein was 
automatically subtracted from the experimental response to take into account any non-specific 
binding.  
Initial control experiments using calmodulin as the analyte were performed to check 
that CaMKII was properly immobilised to the sensor chip surface and capable of binding. 
Increasing concentrations of calmodulin (ranging from 0.0125 – 0.2M) applied to the sensor 
chip surface, resulted in a concentration-dependent increase in binding, reflected in an 
increased response difference (ranging from ~25RU for 0.0125M to ~70 RU for 0.2M 
calmodulin) (Fig. 2A). This was consistent with our previous work [19] and confirmed that 
CaMKII was immobilised sufficiently to the chip surface and capable of interaction. 
IKK  and  were then individually prepared as analytes and each protein was injected over 
the sensor chip at a range of concentrations (0.0125 – 0.2M) in a random manner. This 
concentration range was chosen based on previous SPR studies which have investigated 
protein-protein interactions with components of the NF-B signalling pathway [22]. 
Interestingly, injection of IKK  (Fig. 2B) showed a very clear positive response difference, 
which increased in a concentration-dependent manner (increasing from a difference of ~10RU 
for 0.0125M IKK  to ~ 170RU for 0.2M IKK). This response is much greater than that 
observed for the equivalent concentrations of calmodulin and reflects a strong capacity for 
direct interaction between the two proteins (CaMKII and IKK
Neither IKK nor IKK (Fig. 2C and 2D respectively) showed any positive response 
difference when injected across the chip surface at any of the concentrations tested, 
suggesting there is no direct interaction with CaMKII at higher concentrations (0.1 
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and 0.2M) actually showed a negative change in the response which probably reflects 
differential refractive index changes at flow cells 1 and 2. It is worth noting that this effect 
was only observed for the two highest concentrations of the analyte. 
 
3.3 Assessment of conditions for CaMKIIIKKinteraction 
Having established that there is a direct interaction between CaMKII and IKK , we 
then explored some key regulatory parameters that might affect this. The IKK  used in these 
experiments was HIS-tagged. verify that the observed interaction was not via the HIS-tag 
of IKK , additional experiments were performed in the presence of 100mM imidazole. 
Imidazole is an analogue of histidine and traditionally used to modulate non-specific binding 
when purifying HIS-tagged proteins with affinity gels. As shown in Figure 3A, treatment with 
imidazole had virtually no effect on IKK  binding to the CaMKII sensor chip (~10RU for 
0.0125M IKK  to ~140RU for 0.2M IKK) and showed a similar concentration-dependent 
profile when compared with binding in the absence of imidazole (Fig. 2B). If IKK  was 
interacting with CaMKII via the HIS-tag, then treatment with imidazole should displace 
bound IKKfrom the sensor chip, leading to a dramatic reduction in the observed response. 
The lack of effect of imidazole suggests CaMKII is interacting with IKK  at a site distinct 
from the HIS-tag. 
Since both CaMKII and IKK  are kinases and capable of autophosphorylation, the effect of 
adding ATP to the running buffer was tested (Fig. 3B). It could be that phosphorylation of 
either or both proteins may affect the interaction. Although there was some reduction in 
absolute response in the presence of ATP (120RU (+ATP) v’s 170RU (-ATP) for 0.2M 
IKK), binding was still observed and in a concentration-dependent manner as previously 
(Fig. 2B). This suggests addition of ATP and possible subsequent phosphorylation does not 
prevent interaction but could affect the extent of interaction. Since both proteins are capable 
of phosphorylation, this effect could be at the level of CaMKII and/or IKK 
Finally, the possibility that the interaction may be Ca2+-dependent was examined. Removal of 
Ca2+ from the running buffer had no effect on the CaMKIIIKK  interaction (Fig. 3C) with 
concentration-dependent increases in binding occurring as before and a maximum response 
difference of ~160RU for 0.2M IKK . 

3.4 Characterisation of CaMKII and NF-B signalling components in cardiac fibroblasts  
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  Following on from the use recombinant proteins, follow up experiments were 
conducted in CFs.  CFs were isolated under sterile conditions as described in the methods 
section. Typical CF preparations are shown in Figure 4A(i). Lack of contamination of CFs by 
smooth muscle cells or myofibroblasts was demonstrated by immunostaining with alpha-
smooth muscle actin which did not stain fibroblasts (Fig. 4A (ii)) but did stain colonic smooth 
muscle cells (Fig. 4A (iii)). Cells were also stained for vimentin which is a recognised non-
selective marker for fibroblasts (Fig. 4B (iv)). To determine that CFs were appropriate for 
studying potential interaction between CaMKII and NF-B signalling components, it was 
important to demonstrate that the relevant proteins were expressed in these cells. Whole 
cardiac homogenised tissue (WH) was used as a positive control since we know these proteins 
are expressed in the cardiomyocyte component of homogenates. Immunoblotting shows that 
CaMKII, the active kinases IKK and IKK  as well as IB proteins are all clearly 
expressed in adult CFs (Fig. 4B). 
 
3.5 A functional role for CaMKIIin NF-B signalling – effect of CaMKII inhibition on IB 
degradation in cardiac fibroblasts  
In order to establish whether CaMKII plays a role in the regulation of NF-B signalling, the 
effect of CaMKII inhibition upon IBdegradation was assessed. LPS is a potent activator of 
the NF-B pathway  and was therefore used in this study [22,23].The selective CaMKII 
inhibitor peptide AIP was used (5M for 1h) prior to LPS (5g/ml) stimulation of CFs for the 
indicated periods and degradation of IB monitored by immunoblotting. Treatment with 
LPS resulted in significant IB degradation in CFs over the time course tested (0-60 mins). 
When cells were pre-treated with AIP (5M), IB degradation in response to LPS was 
significantly reversed (Fig. 4C(i)) and this was sustained at 30 minutes, 45 minutes, and in 
some cases 60 minutes of stimulation (mean densitometric data from four separate 
experiments is shown in Figure 4C(ii)). We have previously shown that the concentration of 
AIP used here results in 95-100% inhibition of CaMKII activity in rabbit cardiac preparations 
[19]. This data highlights for the first time the potential for CaMKII in regulating agonist-
stimulated IBdegradation and corresponding activation of NF-B signalling in adult CFs. 
 
3.6 CaMKII interacts with IKK  in cardiac fibroblasts  
Given the results obtained with SPR showing that CaMKII can bind selectively to IKK and 
in light of the fact that CaMKII influences IB degradation in CFs, the possibility that a 
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CaMKII-IKK  interaction may exist in these cells was explored. In order for interaction to 
be detected natively in CFs, Proximity Ligation Assays (PLAs) were employed using primary 
antibodies against the two proteins of interest (CaMKII and IKKβ).  
Initial work was conducted to optimise the primary antibodies using indirect 
immunofluorescence prior to conducting PLA experiments. Signals for IKK  were clearly 
detected (Fig. 5A) however signals obtained using the custom-made CaMKII antibody were 
very weak (Fig. 5B). Whilst both IKKand CaMKII antibodies used here had previously 
been shown to work well for immunoblotting (Fig. 4) it was clear that their utility for 
immunofluorescent-based imaging studies was limited. While the IKK  antibody proved 
suitable for PLA-based experiments, the CaMKII antibody did not.  The approach was 
therefore taken to use a CaMKII antibody directed against the active (oxidised) form of the 
protein (ox-CaMKII). Although it is likely that there will be some ox-CaMKII present in cells 
under basal resting conditions, it is much more likely that levels will rise following activation, 
particularly with a stimulus that drives oxidation. In order to promote oxidation, H2O2 was 
used to treat CFs and the ox-CaMKII signal is shown in immunoblots from CFs following 
treatment with H2O2 (1-10M) (Fig. 5C). Cells were subsequently exposed to 10M H2O2 
prior to PLA. The fluorescence signal for ox-CaMKII from CFs proved to be much greater 
than that obtained using the CaMKII antibody (Fig. 5D). 
Based on these findings, PLAs were conducted using antibodies directed against ox-CaMKII 
and IKK . In CFs treated with H2O2, the fluorescence intensity following incubation with 
both antibodies was significantly greater than incubation with either IKK  alone or both 
antibodies in unstimulated cells (Fig 6A and 6B). This suggests interaction between the 
antibodies (and hence proteins) of interest when cells had been stimulated with H2O2 
signifying greater levels of interaction in activated cells (Fig 6B). 
  
4. Discussion 
There is increasing evidence for a link between CaMKII and NF-B signalling, however our 
understanding of this link in the heart remains limited [15, 16, 24].  This is the first study to 
present evidence for a direct interaction between a specific component of the pathway (IKK) 
and CaMKIIand to demonstrate a functional interaction in CFs. These cells contribute to 
contractile and non-contractile function in normal and diseased heart [25]. Crucially, there is 
strong evidence that CaMKII plays a key role in pathophysiological events in CFs [25, 26] yet 
nothing is known of the potential for CaMKII modulation of pro-inflammatory signalling in 
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these cells. Given that inflammation is a common component of the onset and progression of 
cardiovascular disease, and that both CaMKII and NF-B signalling are central to the 
inflammatory process in cardiac and vascular cells [27,28], it is pertinent to understand (i) 
whether these pathways are inter-dependent in different cells of the heart and (ii) how any 
potential interaction between the two may occur.  
To identify a specific target or targets for CaMKII activity within the NF-B pathway, our 
initial work used recombinant or purified proteins. Autoradiography analysis of IKK 
phosphorylation by CaMKII was performed in the presence and absence of AIP. 
Interestingly, only the phosphorylation associated with IKK  (and not IKK) was 
significantly reduced in the presence of AIP. This suggests that the phosphorylation signal 
associated with IKK is due primarily to autophosphorylation but the phosphorylation 
associated with IKK  is at least partly due to CaMKII-mediated phosphorylation (Fig. 1).  
This indicates that CaMKIImay preferentially associate with and phosphorylate IKKas a 
means of modulating NF-B signalling. This interpretation was strengthened by SPR data 
which clearly showed a selective interaction between IKKand CaMKII but not between 
either IKKor IKK and CaMKII(Fig. 2). The kinetics of IKK  binding were rapid with a 
slower dissociation rate, similar to that observed with calmodulin. Importantly, the extent of 
binding of IKK to CaMKIIwas greater than that observed for calmodulin binding to 
CaMKII (~160RU c.f. ~70RU for 0.2M IKK  and 0.2M calmodulin respectively).  This 
is the first evidence for a direct, selective and high affinity interaction between CaMKII and 
IKKAlthough autoradiographic analysis suggests CaMKII can phosphorylate IKK , the 
interaction between these proteins does not appear to be ATP-dependent, at least when 
analysed by SPR (Fig. 3). 
Previous work has demonstrated the prevalence of IKK  in (i) induction of NF-B activity 
and (ii) modulation of cardiac function. Importantly, for the majority of cellular agonists 
canonical NF-B cannot be activated by agonist stimulation in IKK  deficient cells and 
disruption of the IKK  locus is lethal. In contrast, IKK disruption does not abolish 
activation of the classical IKK complex that mediates canonical NF-B [29], suggesting that 
IKK  plays a more important role in canonical NF-B activation than IKKIn the heart, 
inhibition of IB phosphorylation has been shown to reduce reperfusion injury [30] and 
specific targeting and inhibition of IKK  has provided both acute and delayed 
cardioprotection [31, 32]. This has highlighted IKK  as a potential therapeutic target that 
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could be used to modulate inflammation and cardiac damage following injury. The possibility 
that CaMKII may modulate cardiac NF-B pro-inflammatory signalling via interaction with 
IKK  indicates an important link that could be used for more selective modulation of this 
inflammatory route. The interaction does not appear to be Ca2+-dependent but could be 
affected to some extent by phosphorylation. Further work would be essential to map the 
specific site or sites of interaction between the two proteins to assess this in more detail.  
The present study has shown that adult CFs express key components of NF-B signalling, 
including the IKK complex. These cells also express CaMKII(Fig. 4), which to our 
knowledge, although having been widely examined in the heart, has only received limited 
examination in adult CFs. Initial experiments using CFs examined the potential for interaction 
between CaMKII and NFB signalling by measuring degradation of IBas a functional 
read-out of NF-B activation. IBdegradation was assessed in the presence and absence of 
CaMKII inhibition and using a potent agonist of NF-B activation (LPS). For the first time 
we have demonstrated that inhibition of CaMKII (using AIP pre-treatment) prevents agonist-
stimulated IB degradation/ NF-B activation in these cells (Fig. 5). How CaMKII may 
target NF-B signalling in CFs has not previously been explored however, based on our SPR 
data, the possibility that interaction at the level of IKK  may occur was investigated. Using 
PLA technology (Duolink, Sigma), interaction between CaMKII and IKK  was evident 
following treatment with H2O2. This is a well-known driver of local and systemic 
inflammation in vivo and therefore an appropriate treatment to use in the context of the 
present study [33,34] (Fig. 6). That said, H2O2 may cause aggregation of CaMKII through 
formation of disulphide and non-disulphide bridges so there is the possibility that the presence 
of dimers could affect the PLA signal and this was something we did not explore further in 
the present study. Taking these cell-based experiments as a whole though, this study provides 
crucial evidence for the first time for CaMKII modulation of NF-B in adult CFs. 
Strengthened by recombinant protein work, the present study identifies IKK  as a potential 
novel substrate for modulation by CaMKII and a source through which CaMKII may exert its 
effects on NFB signalling across the cardiovascular system. 
 Given the central importance of CaMKII in cardiac function and dysfunction, it is surprising 
that studies examining its potential role in mediating cardiac inflammation are still relatively 
limited, particularly in relation to non-contractile cells of the heart. Similarly, despite strong 
evidence for altered NF-B signalling in cardiac dysfunction, details of the underlying 
regulatory mechanisms are unclear. This study provides evidence for the first time that 
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CaMKII may modulate NF-B signalling in adult CFs via direct interaction with IKK . The 
possibility of targeting this interaction to modulate cardiac inflammation therapeutically could 
improve specificity on previous approaches for targeting NF-B [35, 36]. The argument exists 
that more selective therapeutic strategies may be less damaging due to lower incidence of off-
target and wider-ranging effects. A key strength of the present study has been the 
investigation in adult CFs, a cardiac cell that, although non-contractile, plays a crucial role in 
modulation of structural integrity as well as indirectly modulating contractile function. 
Activation of NF-B in CFs will induce gene programs that promote inflammation and this 
could potentially be halted across contractile and non-contractile cell types via targeting of the 
CaMKII-IKK  interaction. Further examination of the site(s) of interaction should prove 
informative and will indicate whether CaMKII may phosphorylate unique sites on IKK . This 
could form the basis for disruptive intervention strategies in cardiovascular disease where 
both CaMKII and NF-B signalling are significantly elevated. 
 
5. Conclusion 
In conclusion, we have provided evidence that CaMKII modulates NFB signalling in adult 
CFs and that this occurs, at least in part, via direct interaction with IKK . There is no 
evidence from SPR experiments for interaction of CaMKII with IKK or IKK. Interaction 
between CaMKII and IKK  is elevated under conditions of oxidative stress in CFs, providing 
evidence that CaMKII is an important conduit for pro-inflammatory signalling in non-
contractile myocardial cells and a molecule that could be pivotal to the role these cells play in 
inflammatory cardiac dysfunction. 
 
Acknowledgements 
We thank Mr David Blatchford for expertise in cell imaging, Miss Margaret MacDonald for 
assistance with primary cell isolations and Miss Sarunya Laovitthayanggoon for assistance 
with immunostaining and graphics. This work was supported by the British Heart Foundation 
(grant no: FS/06/066/21409) and BBSRC DTG (grant no: BB/J013854/1).  MRC is a recipient 
of an AMS Springboard award (SBF001\1009). 
 
Disclosures 
The authors declare no conflicts of interest. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
References 
 
[1]  Feng N, Anderson ME (2017) CaMKII is a nodal signal for multiple programmed cell 
death pathways in heart. J Mol Cell Cardiol 103: 102-109 
[2]  Baudino TA, Carver W, Giles W, Borg TK (2006) Cardiac fibroblasts: friend or foe? 
Am J Physiol 291: H1015-H1026 
[5] Matsumori A, Sassayama S (2001) The role of inflammatory mediators in the failing 
heart: immunomodulation of cytokines in experimental models of heart failure. Heart 
Fail Rev 6: 129-136 
[6] Dinh QN, Chrissobolis S, Diep H, Chan CT, Ferens D, Drummond GR, Sobey CG 
(2017) Advanced atherosclerosis is associated with inflammation, vascular 
dysfunction and oxidative stress but not hypertension. Pharmacol Res 116: 70-76 
[7] Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and 
vascular disease. Biochem Pharmacol 78: 539-552 
[8] Purcell NH, Molkentin JD (2003) Is Nuclear Factor B an attractive therapeutic target 
for treating cardiac hypertrophy? Circulation 108: 638-640 
[9] Csiszar A, Wang M, Lakatta EG, Ungvari Z (2008) Inflammation and endothelial 
dysfunction during aging: role of NF-B. J Appl Physiol 105: 1333-1341 
[10] Gamble C, McIntosh K, Scott R, Ho KH, Plevin R, Paul A (2012) Inhibitory kappa B 
kinases as targets for pharmacological regulation. Br J Pharmacol 165, 802-819 
[11] Hughes K, Antonsson A, Grundstrom T (1998) Calmodulin dependence of NFB 
activation. FEBS Lett 441: 132-136 
[12] Hughes K, Edin S, Antonsson A, Grundstrom T (2001) CaMKII mediates T cell 
receptor/CD3 and phorbol ester induced activation of IkB kinase. J Biol Chem 276: 
36008-36013 
[13] Liu AMF, Wong YH (2005) Activation of NF-kB by somatostatin type 2 receptor in 
pancreatic AR42J cells involves G14 and multiple signalling components. J Biol 
Chem 280: 34617-34625 
[14] Kashiwase K, Higuchi Y, Hirotani S, Yamaguchi O, Hikoso S  (2005) CaMKII 
activates ASK1 and NF-B to induce cardiomyocyte hypertrophy. Biochem Biophs 
Res Comm 327: 136-142 
[15] Singh MV, Kapoun A, Higgins L, Kutsche W, Thurman JM, Zhang R, Singh M. Yang 
J, Guan X, Lowe JS, Weiss RM, Zimmermann K, Yull FE, Blackwell TS, Mohler PJ, 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Anderson ME (2009) CaMKII triggers cell membrane injury by inducing complement 
factor B gene expression in the mouse heart. J Clin Invest 119: 986-996 
[16] Ling H, Gray CBB, Zambon AC, Grimm M, Gu Y, Dalton N, Purcell NH, Peterson K, 
Heller Brown J (2013) Ca2+/calmodulin-dependent protein kinase II mediates 
myocardial ischemia/reperfusion injury through nuclear factor-B. Circ Res 112: 935-
944 
[17] Martin TP, Lawan A, Robinson E, Grieve DJ, Plevin RJ, Paul A, Currie S (2014) 
Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin dependent 
protein kinase II in normal and hypertrophied hearts. Pflugers Arch 466: 319-330 
[18] Currie S, Loughrey CM, Craig MA, Smith GL (2004) Calcium/calmodulin dependent 
protein kinase II delta associates with the ryanodine receptor complex and regulates 
channel function in rabbit heart. Biochem J 377: 357-366 
[19] Anthony DF, Beattie J, Paul A, Currie S (2007) Interaction of calcium/calmodulin 
dependent protein kinase IIwith sorcin indirectly modulates ryanodine receptor 
function in cardiac myocytes. J Mol Cell Cardiol 43: 492-503 
[20] Debaize L, Jakobczyk H, Rio A.G, Gandemer V, Troadec M.B. (2017) Optimization 
of proximity ligation assay (PLA) for detection of protein interactions and fusion 
proteins in non-adherent cells: application to pre-B lymphocytes. Mol Cytogen 10:27 
[21] Liu L, Paul A, MacKenzie CJ, Bryant C, Graham A, Plevin RJ (2001) NFB is 
involved in LPS-stimulated induction of interferon regulatory factor 1 and GAS/GAF 
DNAbinding in HUVECs. Br J Pharmacol 134: 1629-1638 
[22] Cruz MT, Duarte CB, Goncalo M, Carvalho AP, Lopes MC (2001) LPS induction of 
IB degradation and iNOS expression in a skin dendritic cell line is prevented by the 
Janus kinase 2 inhibitor, Tyrphostin B42. Nitric Oxide Biol. Chem. 5: 53-61 
[23] Buchele B, Zugmaier W, Lunov O, Syrovets T, Merfort I, Simmet T (2010) Surface 
Plasmon Resonance analysis of NF-kappa B protein interactions with the 
sesquiterpene lactone helenalin. Anal Biochem 401: 30-37 
[24] Gray CBB, Suetomi T, Xiang S, Mishra S, Blackwood EA, Glembotski CC, 
Miyamoto S, Westenbrink D, Heller Brown J (2017) CaMKII subtypes differentially 
regulate infarct formation following ex vivo myocardial ischemia/reperfusion through 
NFB and TNF J Mol Cell Cardiol 103: 48-55 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
[25] Vasquez C, Benamer N, Morley GE (2011) The cardiac fibroblast: functional and 
electrophysiological considerations in healthy and diseased hearts. J Cardiovasc 
Pharmacol 57: 380-388 
[26] Zhang W, Chen D, Feng Q, Wang J, Xiao W, Zhu W (2010) Inhibition of Calcium-
Calmodulin dependent Kinase II suppresses cardiac fibroblast proliferation and 
extracellular matrix secretion. J Cardiovasc Pharmacol 55: 96-105 
[27] Weinreuter M, Kreusser MM, Beckendorf J, Schreiter FC, Leuschner F, Lehmann LH, 
Hofmann KP, Rostosky JS, Diemert N, Xu C, Volz HC, Jungmann A, Nickel A, Sticht 
C, Gretz N, Maack C, Schneider MD, Grone HJ, Muller OJ, Katus HA, Backs J 
(2014) CaM kinase II mediates maladaptive post-infarct remodelling and pro-
inflammatory chemoattractant signalling but not acute myocardial 
ischemia/reperfusion injury. EMBO Mol Med 6: 1231-1245 
[28]  Valen G, Yan Z, Hansson GK (2001) Nuclear Factor Kappa-B and the heart. J Am 
Coll Cardiol 38: 307-314  
[29] Li B, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M (1999) 
The IKK  subunit of IkB kinase (IKK) is essential for nuclear factor B activation 
and prevention of apoptosis. J Exp Med 189: 1839-1845 
[30] Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fukasawa H, Muto S, Itai A, 
Mitsuaki I (2004) Inhibition of IkB phosphorylation in cardiomyocytes attenuates 
myocardial ischaemia/reperfusion injury. Cardiovasc Res 63: 51-59 
[31] Moss NC, Stansfield WE, Willis MS, Tang R, Selzman CH (2007) IKK  inhibition 
attenuates myocardial injury and dysfunction following acute ischemia-reperfusion 
injury. Am J Physiol 293: H2248-H2253 
[32] Moss NC, Tang R, Willis M, Stansfield WE, Baldwin AS, Selzman CH (2008) IKK  
is a target for specific nuclear factor kappa B-mediated delayed cardioprotection. J 
Thor Cardiovasc Surg 136: 1274-1279 
[33] Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, 
Pestell RG, Howell A, Sotgia F (2011) Hydrogen peroxide fuels ageing, inflammation, 
cancer metabolism and metastasis: the seed and soil also needs ‘fertilizer’. Cell Cycle 
10: 2440-2449 
[34] Van der Vliet A, Janssen-Heininger YM (2014) Hydrogen peroxide as a damage 
signal in tissue injury and inflammation: murderer, mediator or messenger? J Cell 
Biochem 115: 427-435 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
[35] Gupta S, Young D, Sen S (2005) Inhibition of NF-{kappa}B induces regression of 
cardiac hypertrophy, independent of blood pressure control, in spontaneously 
hypertensive rats. Am.J.Physiol. 289: H20-29 
[36] Gupta S (2008) Prevention of cardiac hypertrophy and heart failure by silencing of 
NFkappaB. J.Mol. Biol. 375: 637-64 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Figure legends 
 
Fig. 1. Phosphorylation profiles of CaMKII  IKKand IKK following co-incubation 
with ATP (A) CaMKII(30ng) was incubated with either IKK or IKK  (both at 100ng) at 
30oC for 30 minutes in the presence of [32P]ATP and in the presence (lanes 5 and 6) or 
absence (lanes 3 and 4) of AIP (5M). Equivalent loads of sample were subjected to 
electrophoresis and incorporation of phosphate into CaMKII and IKKs was detected using 
autoradiography. Representative autoradiogram data is shown as relevant sections from one 
autoradiogram (representative of two others) where the same batch of CaMKII was 
incubated with IKKs and the exposure time consistent across all lanes. (B) Purity of 
individual proteins CaMKII, IKK and IKK  (100ng each) was shown by coomassie 
staining of a gel following electrophoresis. 
 
Fig. 2. SPR analysis reveals that IKK  interacts directly with CaMKII in a 
concentration dependent manner but IKK  and IKK  do not. The potential for 
CaMKIIinteraction with components of the IKK complex was analysed by SPR. 
Calmodulin (A), IKKB), IKKC) and IKKD) proteins (0.0125-0.2M) were injected 
across a CaMKIIsurface which had ~7000RU immobilised protein (~7pg/mm2). Analytes 
were injected in duplicate and in random order with respect to concentration. Association was 
monitored for 3 min and dissociation for 15 min. Binding surfaces were regenerated following 
2 x 30s pulses with regeneration reagent (100mM HCl, 0.5M NaCl). A control flow cell 
contained BSA immobilised at equivalent levels to CaMKII and responses from this flow 
cell together with the response to zero analyte were subtracted from the experimental 
responses. Data is representative of 3 independent experiments, performed in duplicate. For 
clarity only a single response at each analyte concentration is shown. 
 
Fig. 3. The CaMKII -IKK  interaction does not occur via the HIS-tag on IKK  nor is it 
affected by the presence of ATP or removal of Ca2+. The CaMKII-IKK interaction was 
explored in more detail using SPR analysis performed under different running conditions. 
IKK  was injected over a range of concentrations (0.0125-0.2M) across a CaMKII-
immobilised sensor chip as previously. (A) To assess possible binding via the HIS-tag of 
IKK , 100mM imidazole was included in the running buffer. (B) To assess whether 
phosphorylation (inclusion of ATP) may be an important requirement for the interaction, 
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1mM ATP was included in the running buffer. (C) To determine whether the interaction may 
be Ca2+-dependent, analysis was performed in the absence of CaCl2. Data for each condition 
is representative of two other independent experiments. 
 
Fig. 4. Agonist-induced IB  degradation in cardiac fibroblasts is reversed following 
CaMKII inhibition. (A(i)) A typical population of adult rat cardiac fibroblasts (p1) in culture 
(x20 magnification). (B) CFs were double-stained for (i) vimentin/DAPI (ii) von-Willebrand 
factor(vWF)/DAPI (iii) CD31/DAPI and (iv) -smooth muscle actin/DAPI to check for any 
contamination with endothelial cells, smooth muscle cells or myofibroblasts. Positive controls 
included endothelial cells stained with (v) vWF/DAPI and (vi) CD31/DAPI and smooth 
muscle cells stained with -SMA. Nuclei are stained blue with DAPI and antibody staining is 
shown in green and red from FITC or Alexa-Fluor 594. Panels i-iv were obtained using 20x 
objective and panels v-vi used the 10x objective. (C) Cardiac fibroblasts or whole 
homogenate preparations were solubilised in Laemmli sample buffer as described in the 
methods section and protein expression was examined by immunoblotting. Total protein from 
either 2x104 cells (CF) or 20g whole cardiac homogenate used as a positive control (WH) 
was probed for expression of CaMKII, IKK IKK  and IB.  This data is from an 
individual experiment, typical of two others. (D(i)) Representative immunoblot showing LPS-
induced IκBα degradation in the presence or absence of CaMKII inhibitor AIP (5µM). (D(ii)) 
Densitometric analysis was performed and all data normalised to GAPDH. All data are 
expressed as mean ± S.E.M, n=3, *p<0.05. 
 
Fig. 5. IKK  and oxidised CaMKII can both be detected in cardiac fibroblasts using 
immunofluorescence. (A) Images showing positive staining for IKKβ by 
immunofluorescence in CFs. Cells were fixed, permeabilised and incubated with primary 
anti-IKKβ antibody (1:200) (Abcam) overnight at 4°C and anti-mouse FITC conjugated 
secondary antibody (1:200) under basal conditions. Cells stained with secondary antibody 
alone served as a negative control. Nuclei were counterstained with DAPI. (B) Similar 
experiments were performed to assess CaMKIIδ expression (1:50 (Eurogentec, custom-made) 
followed by anti-rabbit TRITC conjugated secondary antibody (1:200) incubation. Secondary 
antibody alone was again used as a negative control. (C) Representative immunoblots 
showing sensitivity of ox-CaMKII antibody (1:1000) (GeneTex) to treatment of CFs with 
increasing concentrations of H2O2 (1h). All data was normalised to GAPDH and 10µM H2O2 
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selected as the optimal concentration. (D) Images showing ox-CaMKII expression as detected 
by immunofluorescence (1:50) following under basal conditions and following treatment with 
10µM H2O2. Anti-rabbit TRITC conjugated secondary antibody (1:200) alone was used as a 
negative control. All images are from one experiment, representative of two others. 
 
Figure 6. PLA analysis of oxidised CaMKII-IKK  binding in cardiac fibroblasts. (A) 
Proximity Ligation Assay (PLA) data showing ox-CaMKII-IKKβ interaction in CFs 
following H2O2 (10µM) stimulation (bottom right panel). The interaction was also assessed 
under basal conditions (bottom left panel). Controls were included where no primary antibody 
incubation was used (control, top left panel) or IKKantibody alone (top right panel) was 
used.(B) Quantification of signals was performed using four images per treatment group and 
counting number of fluorescent dots/cell as shown in histogram. Statistical analysis was 
performed using a one-way ANOVA followed by Tukey’s post-test. All data is presented as 
mean ± S.E.M of fluorescent dots/cell, n=3, *p<0.05, ***p<0.001. 
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Highlights 
 Surface Plasmon Resonance using recombinant or purified proteins demonstrates that 
CaMKII interacts directly with IKK  but does not interact with IKK or IKK. 
 Pharmacologically- induced NFB activation in adult cardiac fibroblasts is inhibited 
following selective CaMKII inhibition.  
 Interaction between CaMKII and IKK  in adult cardiac fibroblasts is evident under 
conditions of oxidative stress. 
 CaMKII is an important modulator of NFB signalling in adult cardiac fibroblasts.  
ACCEPTED MANUSCRIPT
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
